An in vitro verification of strength estimation for moving an 125I source during implantation in brachytherapy

被引:3
|
作者
Tanaka, Kenichi [1 ]
Kajimoto, Tsuyoshi [1 ]
Hayashi, Takahiro [1 ]
Asanuma, Osamu [2 ]
Hori, Masakazu [3 ]
Kamo, Ken-ichi [3 ]
Sumida, Iori [4 ]
Takahashi, Yutaka [4 ]
Tateoka, Kunihiko [3 ]
Bengua, Gerard [5 ]
Sakata, Koh-ichi [3 ]
Endo, Satoru [1 ]
机构
[1] Hiroshima Univ, Grad Sch Engn, Quantum Energy Applicat, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7398527, Japan
[2] Sapporo Med Univ Hosp, Div Radiol & Nucl Med, Chuo Ward, South 1,West 17, Sapporo, Hokkaido 0608556, Japan
[3] Sapporo Med Univ, Grad Sch Med, Dept Radiat Oncol, Chuo Ward, South 1,West 16, Sapporo, Hokkaido 0608543, Japan
[4] Osaka Univ, Grad Sch Med, Dept Radiol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan
[5] Auckland City Hosp, Pk Rd, Auckland 1142, New Zealand
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
brachytherapy; I-125; source strength; moving source; verification; INTERSTITIAL BRACHYTHERAPY; DOSIMETRY;
D O I
10.1093/jrr/rry021
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aims to demonstrate the feasibility of a method for estimating the strength of a moving brachytherapy source during implantation in a patient. Experiments were performed under the same conditions as in the actual treatment, except for one point that the source was not implanted into a patient. The brachytherapy source selected for this study was I-125 with an air kerma strength of 0.332 U (mu Gym(2)h(-1)), and the detector used was a plastic scintillator with dimensions of 10 cm x 5 cm x 5 cm. A calibration factor to convert the counting rate of the detector to the source strength was measured and then the accuracy of the proposed method was investigated for a manually driven source. The accuracy was found to be under 10% when the shielding effect of additional needles for implantation at other positions was corrected, and about 30% when the shielding was not corrected. Even without shielding correction, the proposed method can detect dead/dropped source, implantation of a source with the wrong strength, and a mistake in the number of the sources implanted. Furthermore, when the correction was applied, the achieved accuracy came close to within 7% required to find the Oncoseed 6711 (I-125 seed with unintended strength among the commercially supplied values of 0.392, 0.462 and 0.533 U).
引用
收藏
页码:484 / 489
页数:6
相关论文
共 50 条
  • [31] Contamination Resulting From a Broken 125I Seed During a Brachytherapy Procedure
    Buckley, Lesley
    Fraser, Danielle J.
    MacPherson, Miller
    Foottit, Claire
    HEALTH PHYSICS, 2021, 121 (05): : 531 - 534
  • [32] Early prostate cancer:: LDR prostate brachytherapy with 125I permanent implantation;: Experience at CROB
    Cocco, G.
    Iadanza, L.
    Zucca, S.
    Castaldo, G.
    Lapadula, L.
    Montagna, A.
    Mazziotta, M.
    Imbriani, E.
    Silvestre, G.
    Fusco, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI80 - XI80
  • [33] The Monte Carlo simulated prostate Brachytherapy implantation with 48 IsoAid Advantage™ 125I sources
    Zhang, H
    Meigooni, A
    MEDICAL PHYSICS, 2003, 30 (06) : 1333 - 1333
  • [34] Experimental determination of the dosimetric characteristics for the I-Plant™ model 3600 125I brachytherapy source
    Tries, MA
    Mancevice, CG
    Munro, JJ
    MEDICAL PHYSICS, 2005, 32 (06) : 1469 - 1472
  • [35] Development of production technology of 125I seed for brachytherapy
    Han, Hyon-Soo
    Park, Ul-Jae
    Son, Kwang-Jae
    Lee, Jun-Sig
    Hong, Soon-Bog
    Nam, Sung-Soo
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6): : 321 - 322
  • [36] Urinary morbidity after 125I brachytherapy of the prostate
    Mallick, S
    Azzouzi, R
    Cormier, L
    Peiffert, D
    Mangin, P
    BJU INTERNATIONAL, 2003, 92 (06) : 555 - 558
  • [37] Urinary morbidity after 125I brachytherapy of the prostate
    Henderson, A
    Bott, SRJ
    Sooriakumaran, P
    Laing, RW
    Langley, SEM
    BJU INTERNATIONAL, 2004, 93 (06) : 890 - 890
  • [38] Postenucleation orbits in retinoblastoma:: Treatment with 125I brachytherapy
    Stannard, C
    Sealy, R
    Hering, E
    Hough, J
    Knowles, R
    Lecuona, K
    Reddi, VB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05): : 1446 - 1454
  • [39] 125I brachytherapy in younger prostate cancer patients
    Kindts, Isabelle
    Stellamans, Karin
    Billiet, Ignace
    Pottel, Hans
    Lambrecht, Antoon
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 707 - 713
  • [40] 125I interstitial brachytherapy for the gliomaectomized patients.
    Wang, J
    Wang, LG
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 317P - 317P